您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览35

Lifetime risk estimates of chronic kidney disease (CKD) can motivate preventative behaviors at the individual level and forecast disease burden and health care use at the population level.Markov Monte Carlo model simulation study.Current US black and white population.Markov models simulating kidney disease development, using an individual perspective and lifetime horizon.Age-, sex-, and race-specific residual lifetime risks of CKD stages 3a+ (estimated glomerular filtration rate [eGFR] <60 mL/min/1.73 m²), 3b+ (eGFR <45 mL/min/1.73 m²), 4+ (eGFR <30 mL/min/1.73 m²), and end-stage renal disease (ESRD).State transition probabilities of developing CKD and of dying prior to its development were modeled using: (1) mortality rates from the National Vital Statistics Report, (2) mortality risk estimates from a 2-million person meta-analysis, and (3) CKD prevalence from National Health and Nutrition Examination Surveys. Incidence, prevalence, and mortality related to ESRD were supplied by the US Renal Data System.At birth, the overall lifetime risks of CKD stages 3a+, 3b+, 4+, and ESRD were 59.1

作者:Morgan E, Grams;Eric K H, Chow;Dorry L, Segev;Josef, Coresh

来源:American journal of kidney diseases : the official journal of the National Kidney Foundation 2013 年 62卷 2期

相似文献
知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:35
作者:
Morgan E, Grams;Eric K H, Chow;Dorry L, Segev;Josef, Coresh
来源:
American journal of kidney diseases : the official journal of the National Kidney Foundation 2013 年 62卷 2期
标签:
Chronic kidney disease end-stage renal disease incidence lifetime risk
Lifetime risk estimates of chronic kidney disease (CKD) can motivate preventative behaviors at the individual level and forecast disease burden and health care use at the population level.Markov Monte Carlo model simulation study.Current US black and white population.Markov models simulating kidney disease development, using an individual perspective and lifetime horizon.Age-, sex-, and race-specific residual lifetime risks of CKD stages 3a+ (estimated glomerular filtration rate [eGFR] <60 mL/min/1.73 m²), 3b+ (eGFR <45 mL/min/1.73 m²), 4+ (eGFR <30 mL/min/1.73 m²), and end-stage renal disease (ESRD).State transition probabilities of developing CKD and of dying prior to its development were modeled using: (1) mortality rates from the National Vital Statistics Report, (2) mortality risk estimates from a 2-million person meta-analysis, and (3) CKD prevalence from National Health and Nutrition Examination Surveys. Incidence, prevalence, and mortality related to ESRD were supplied by the US Renal Data System.At birth, the overall lifetime risks of CKD stages 3a+, 3b+, 4+, and ESRD were 59.1